Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Enhertu granted Orphan Drug Designation in the US for gastric cancer
-
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
-
Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer
-
Enhertu granted Breakthrough Therapy Designation in the US for HER2-mutant metastatic non-small cell lung cancer
-
Bevespi Aerosphere approved in China for patients with COPD
-
AstraZeneca advances the science of cancer medicine with practice-changing data at the ASCO20 Virtual Scientific Program
-
Enhertu granted Breakthrough Therapy Designation in the US for HER2-positive metastatic gastric cancer
-
AstraZeneca recovery of global rights to brazikumab (MEDI2070) from Allergan completed
-
Lynparza approved in the US as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
-
Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction
Latest articles and press releases
All of our latest press releases and articles are available to explore
